Real Estate Chart Deep Dive - Spreads are Tight and Seasoned Housing is Strong

The Doctor is IN | November 2024

BioNTech the Lone Large Acquirer in November as Biotech Waits Clarity Post Election

November 2024 Riffin' on Real Estate

October Marked the 13th Time in the Past 34 Months That Bonds Declined Alongside Equities. We Need Another Solution to Bonds

October Sees $4B+ in M&A Deals as Health Stocks Enter Earnings Season and Wait on Election and Rate Moves. Longboard Acquistion Over $2.6B

Abbvie Deal Shoots Stock Up. Biotech Hugging the Moving Average as Bond Yields Interrupt Momentum.

A Quarterly Look at Housing and the MREIT Sector - Residential Still a Bright Spot with Bond Outlook Improving

Biotech Testing 100-Day Moving Average Amidst Earnings and Election Seasons

XBI Rallies to 50-Day Moving Average as Markets Digest Hotter Than Expected CPI and Rate Cut Futures

The VIX Spikes and Then Goes Right Back to Normal - That's Not Normal

Biotech Capital Markets Overview - Deal Action Slowing Down Waiting for Market Tailwinds

Fed Rate Cut Expectations Dropping as 10-Year Goes Up. Biotech Indices Slide as Tailwinds Soften

Biotech Steady Amidst Rate Moves and Political Uncertainty

March 2024 Follow-Up with the Doctor

September 2024 Follow-Up with the Doctor

Novo Nordisk Meets with the Senate Under Pressure to Reduce Prices as Biotech Takes a Breather After Rate Cuts

Biotech M&A Activity through September 13th - Rate Cut the Tailwind Sector Has Been Waiting For

The Long and Short of Commodity Investing